leisure time -WSS

leisure time

author：comprehensive 2025-09-29 21:25:35 - browse：27

Emergent BioSolutions, the manufacturing company that fell into hot water in 2021 due to a contamination issue involving millions of doses of Covid vaccines, is pivoting its business and cutting hundreds of jobs, including a C-suite role.

The company announced Tuesday that it will cut 400 jobs and eliminate the role of chief operating officer as part of a shift away from its contract manufacturing services business. The current chief operating officer, Adam Havey, will leave the company on Sept. 30.

Instead, Emergent will focus on producing Narcan nasal spray and other products. The overdose reversal medicine became available as an over-the-counter medicine earlier this year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Allen Institute goes after foundational questions, CEO Costa says

entertainment

WSS

Reconstructing family trees of blood cells may help predict disease

Gene therapy denied for Afghan refugee whose father aided U.S.

JPM pitch from hospitals? Revenue streams outside of patient care

STAT Virtual Event: JPM Recap, Live!

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Biogen walks away from Aduhelm, years after polarizing approval

leisure time

leisure time

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Investment in vaccine development is lagging, report finds

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

The cancer drug shortage isn’t new — and neither are the solutions

New clues to why women have higher risk of autoimmune disorders

Moonlake's readout produced a cash windfall. Risks remain

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Vertex non

knowledge

American taxpayers paid $1.8 trillion in health care costs in 2022

Wegovy leads to weight loss. Can it treat depression, too?

10 reasons why health care startups fail

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Investment in vaccine development is lagging, report finds

Venture capital firm's plans to take over Akron hospital face hurdles

entertainment

leisure time

explore

explore